RecruitingNot ApplicableNCT03832712

The Swedish Essential Tremor (SWEET) Trial

The Swedish Essential Tremor (SWEET) Trial - A Multicentre Randomized Controlled Trial of Deep Brain Stimulation for Essential Tremor

Sponsor

Karolinska Institutet

Enrollment

100 participants

Start Date

Jun 30, 2018

Study Type

INTERVENTIONAL

Conditions

Essential Tremor

Summary

To evaluate the effect of deep brain stimulation (DBS) vs best medical treatment in essential tremor (ET) in a randomized, single-blinded controlled trial.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria1

Diagnosis of ET, as decided by the movement disorder specialist; Substantial incapacity; Duration of symptoms > 5 years; Age 18 - 75; unsatisfying effect from β-blockers, or be unable to tolerate the medical therapy.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREDeep Brain Stimulation

Surgical implantation of intracranial leads for deep brain stimulation, extension cables and implantable pulse generator

DRUGBest Medical Treatment

Unselective β-blockers such as Propanolol

Locations(6)

Sahlgrenska University Hospital

Gothenburg, Sweden

Linköping University Hospital

Linköping, Sweden

Lund University Hospital

Lund, Sweden

Karolinska University Hospital

Stockholm, Sweden

Umeå University Hospital

Umeå, Sweden

Akademiska Sjukhuset

Uppsala, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03832712

Related Trials

Deep Brain Stimulation Surgery for Movement Disorders

NCT015815801 location

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

NCT065536254 locations